Analysis of Factors Associated with Compliance with Hepatitis B Examination in Pregnant Women in the Kassi Kassi Health Center Working Area, Makassar City in 2023

Hepatitis B testing is crucial for pregnant women due to its potential impact on maternal and fetal health.In Indonesia, uptake of hepatitis B testing among pregnant women remains suboptimal.A 2019 survey revealed only 48.25% of the targeted pregnant women underwent testing nationwide.Similarly, a 2023 survey in Makassar reported just 43% compliance.At Kassi Kassi Community Health Center from 2020 to 2022, only 57.88% of pregnant women were tested.This study aimed to identify factors influencing compliance with hepatitis B testing among pregnant women in the Kassi Kassi Health Center area, Makassar City in 2023.A cross-sectional study included 215 pregnant women using purposive sampling.Bivariate analysis employed Univariate analysis showed 54.0% of pregnant women did not comply with hepatitis B testing.Factors included healthy reproductive age (81.4%), higher education (76.7%), insufficient knowledge (89.8%), and negative attitudes (89.8%).Multiparity (60.9%), proximity to health services (58.6%), lack of information sources (53.0%), and absence of husband's support (81.4%) also influenced compliance.Bivariate analysis revealed significant relationships with education, knowledge, attitudes, proximity to health services, information sources, and husband's support.Multivariate analysis highlighted information sources as the most influential factor.Hepatitis B testing compliance among pregnant women is low, influenced by education, knowledge, attitudes, proximity to health services, information sources, and husband's support.Improving public health knowledge, especially on hepatitis B transmission, through educational campaigns and accessible information media like brochures and banners, is crucial.These efforts can enhance compliance rates and maternal health outcomes in Makassar City.